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1. Introduction 
Nuclear magnetic resonance spectroscopy (NMR) 
has been shown to be a valuable method for studying 
the contents of intact cells [ 1,2]. Most studies have 
involved 3’P NMR, but other nuclei such as ‘H, 13C 
and “N have also been investigated [3-51. Resolvable 
NMR signals are generally observed only from molecules 
which are present in relatively high concentrations, 
and which give rise to narrow lines. This generally 
restricts observation to small molecules which are not 
strongly bound to large proteins or to membranes. 
Here we describe 19F and 31P NMR studies of 
human platelets. These cells possess two well defined 
regions, the cell cytoplasm and membrane-enclosed 
storage vesicles (dense bodies), each containing 
molecules of low molecular weight in concentrations 
sufficiently high to be observable by NMR. Platelet 
cytoplasm contains inorganic phosphate (pi), sugar 
phosphates, and a metabolic pool of adenine 
nucleotides believed to serve as the energy source 
for most cellular functions [6,7]. The vesicles contain 
high concentrations of serotonin (5-hydroxytrypt- 
amine), ADP, ATP, pyrophosphate and Ca*+ [8-l 11. 
The purpose of the work described here is to identify 
resonances from molecules in the different cellular 
regions, and to obtain information about the freedom 
of motion of molecules in the different regions. This 
is done to provide the basis for future studies of 
platelet physiology and the factors governing the 
transport of molecules between the different compart- 
ments. 
To our knowledge 19F NMR has not yet been 
applied to the study of intact cells. However, i9F is 
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an attractive nucleus for this purpose because: 
(i) Its sensitivity is high; 
(ii) It is possible to introduce specific “Flabelled 
molecules into specific compartments of the cell; 
(iii) Spectra can be obtained without the complica- 
tions of overlapping resonances. 
We have used two methods to introduce fluorinated 
molecules into platelets. 
1. To allow uptake of a specific fluorinated molecule, 
here 4,6-difluoroserotonin, > 90% of which is 
incorporated into the vesicular region [ 1 I]. 
2. To rely on biosynthesis of a molecule of interest 
from a precursor fluorinated molecule which is 
taken up by the cell. 
Thus, incubation of the platelets with 2-fluoro- 
adenosine results in the accumulation of 2-fluoro-ATP 
in the cytoplasmic region [ 121. There is essentially no 
exchange of ATP (or 2-fluoro-ATP) between the 
cytoplasmic and the vesicular regions [ 12,13 1. Thus 
19F probes can be incorporated specifically into the 
different regions of the cell. 
2. Materials and methods 
4,6-difluoroserotonin and 2-fluoroadenosine were 
synthesized by the procedures in [ 14,151. Antimycin 
A, 2-deoxy-D-glucose and nucleotides were obtained 
from Sigma. The ionophore X537A was the generous 
gift of Dr J. Berger of Hoffman-LaRoche. Other 
chemicals were all reagent grade. 
For each experiment, 4 units of platelet-rich plasma 
(PRP) were obtained from a single donor by collection 
in ACD-A anticoagulant and differential centrifuga- 
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tion [ 161. Donors had no history of hematologic dis- 
orders or drug ingestion for at least 10 days prior to 
donation. For 31P NMR studies, PRP was incubated 
overnight at 22°C with 2 X 10m5 M adenine (to raise 
intracellular nucleotide levels [9,17]). For 19F NMR 
studies of cells containing 4,6-difluoroserotonin, PRP 
was incubated overnight at 22°C with 2 X lo-’ M 
adenine, and subsequently for 60 min at 37°C with 
2 X lo-’ M 2,6-difluoroserotonin. For 19F NMR 
studies of cells containing 2-fluoro-ATP, PRP was 
incubated overnight with 5 X lo-’ M 2-fluoro- 
adenosine. All PRP was then diluted 1: 1 (v/v) with 
buffer similar to that in [ 181 but containing 2 mM 
EDTA, 0.35% human serum albumin and no glucose, 
cooled to 4”C, and spun at 4500 X g for 5 min. Platelets 
were resuspended in 50 ml total vol. of the same 
buffer;cellsintended for 19F NMRstudies of 2-fluoro- 
ATP were further incubated for 60 min at 37°C with 
lo-“ M 2fluoroadenosine. Cells were pelleted 
(1000 X g for 20 min), and resuspended (in glucose- 
free buffer made up with DzO) so that the final 
volume contained -50% cells and 50% buffer. 
Resuspended platelets were maintained at O’C. 
Aliquots were treated: 
(0 
(ii) 
With 2-deoxy-D-glucose (20 mM final cont.) and 
antimycin A (8.2 pg/ml final cont. [19]), 
incubated at 37’C for 60 min, then cooled to 0°C; 
with X537A (25 PM final cont. [20]), incubated 
at 37’C for 1 min, then cooled to 0°C. Cell 
extracts were prepared by the addition of per- 
chloric acid (final cont. 0.4 N), incubation for 
5 min at room temperature, followed by addition 
of EDTA and neutralization to pH 7.5 by the 
addition of NaOH. 
19F NMR spectra were recorded at 254 MHz using 
a Bruker spectrometer with 5 mm diam. sample 
tubes, and at 94 MHz using a Varian XL-1 00 spectrom- 
eter with 12 mm diam. sample tubes. 31P NMR 
spectra were recorded at 109.3 MHz using the Bruker 
spectrometer with 15 mm diam. sample tubes. All 
spectra were recorded at 4°C in the Fourier transform 
mode without ‘H noise decoupling. 
3. Results 
Figure l(c) shows a 254 MHz 19F NMR spectrum 
of platelets incubated with 4,6difluoroserotonin. 
(a) 
Id 
F&l. 254 MHz 19F NMR spectra of: (a) 1 mM 4,6difluoro- 
scrotonin, 3000 scans; (b) perchloric acid extract of platelets 
incubated with 4,6difluoroserotonin, 5000 scans; (c) intact 
platelets incubated with 4,6difluoroserotonin, 39 000 scans. 
Chemical shifts are in ppm from C,F,. 
Despite a long accumulation time, no resonances 
could be detected either at this frequency or at 
94 MHz. However, lysis of a portion of these cells 
with perchloric acid showed clearly the expected 19F 
resonances (fig.l(b)). Similarly, treatment of other 
portions of these cells with X537A or with 2-deoxy- 
D-glucose and antimycin A resulted in the appearance 
of well-resolved resonances, following release of 
4,6-difluoroserotonin to the extracellular medium 
[21,22]. Thus, not only do the intact cells contain 
sufficient 4,6-difluoroserotonin to be readily observed 
by NMR if the resonances are sharp, but also the 
presence of intact cells does not interfere with 
observation of resonances from extracellular material. 
We therefore conclude that the 19F resonances of 
4,6-difluoroserotonin contained in the vesicles are 
extremely broad. 
Figure 2(b) shows the 254 MHz 19F NMR spectrum 
of platelets incubated with 2fluoroadenosine. The 
observed peak has a linewidth of 240 Hz at this 
frequency, but at 94 MHz the linewidth is only 
100 Hz. The spectrum of the perchloric acid extract 
contained a sharp resonance with a chemical shift 
different by 0.09 ppm from that of 2-fluoro- 
adenosine. The chemical shift difference was clearly 
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Fig.2.254 MHz 19F NMR spectra of: (a) 5 mM 2-fluoro- 
adenosine, 500 scans; (b) platelets incubated with Z-fluoro- 
adenosine, 5000 scans; (c) platelets incubated with 2-fluoro- 
adenosine, then treated with 2deoxy-D-glucose and anti- 
mycin A, 3000 scans. Chemical shifts are in ppm from 
2-fluoroadenosine. 
seen by addition of 2-fluoroadenosine to the 
extract. 2-fluoro-ATP has been shown [ 131 to 
accumulate in cells under the conditions used here, 
and we therefore attribute the observed resonance in 
both the extract and the intact cells to this compound. 
(In the spectrum of the extract another resonance 
with an intensity of < 10% of that of the above 
resonance was also observed. This had a chemical shift 
very close to that of 2fluoroadenosine, and pre- 
sumably arose from this compound or from 2-fluoro- 
AMP.) Treatment of the cells with the metabolic 
poisons 2-deoxy-D-glucose and antimycin A results in 
a spectrum (fig.2(c)) containing a peak having a line- 
width much narrower than that of the untreated 
platelets. The spectrum of the perchloric acid extract 
of these poisoned cells showed that the peak assigned 
to 2-fluoro-ATP had disappeared, and that a new 
peak with a chemical shift close to that of 2-fluoro- 
adenosine had appeared. As 2-fluoro-AMP is known 
[23] to accumulate in platelets treated in this way, it 
is likely that the observed signals in the extract and in 
the intact cells arise primarily from this compound. 
Figure 3(a) shows the 31P NMR spectrum of 
platelets. Resonances from sugar phosphate, inorganic 
phosphate (pi) and ATP are well resolved. Treatment 
with 2-deoxy-D-glucose and antimycin A results in 
substantial changes in this spectrum, revealed clearly 
in the difference spectrum. Without treatment, the 
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Fig.3. 109 MHz ‘*P NMR spectra of: (a) untreated platelets; 
(b) platelets treated with 2deoxy-D-glucose andantimycin A. 
The difference (a)-(b) is plotted, and the high field region 
of each spectrum is shown expanded by a factor of two in 
the vertical scale. Peak assignments: (1) 2deoxy-D-glucose- 
6phosphate; (2) sugar and nucleotide monophosphates; 
(3) Pi; (4) ATP y- and ADP @- ; (5) ATP (Y- and ADP (Y- ; 
(6) ATP p-, OI-, p-and y-refer to positions of phosphates, 
OL- being adjacent o the CH, groups of ribose. Chemical shifts 
are from external phosphoric acid. 
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provided that the cells are maintained at 4°C. Treat- 
ment with metabolic poisons has resulted in an 
increase in the intensity of the Pi peak (and a slight 
shifts due to a pH change), and appearance of a new 
peak in the sugar phosphate region (with a chemical 
shift identical to that of 2-deoxy-D-glucose-6-phos- 
phate), and a decrease in the intensity of the ATP 
resonances. The difference spectrum reveals clearly 
the three ATP resonances which have different line- 
widths, that of the P-phosphate being broader by a 
factor of about two than those of the (Y- and 
y-phosphates. Treatment in this way is expected to 
cause a total breakdown of cytoplasmic ATP [ 191, 
hence increasing the peak intensity Of Pi and producing 
a peak of phosphorylated 2-deoxy-D-glucose, with- 
out significant change in the vesicular contents [22]. 
Spectrum 3(b), therefore, is expected to contain 
resonances from vesicular ATP, ADP and pyro- 
phosphate. However the only resonances which 
can possibly be attributed to these compounds are 
two very broad ones, in the positions expected for 
ATP (a- and y-phosphates) or ADP (a- and P-phos- 
phates). No resonances attributable to the P-phosphate 
of ATP or to pyrophosphate can be detected. How- 
ever, perchloric acid extracts of the cells (fig.4) show 
that indeed the treated cells do contain ADP, ATP 
and pyrophosphate, and that the effects of 2-deoxy- 
D-glucose and antimycin A on the platelets are to 
decrease the total concentration of ATP, and to 
increase the concentrations of Pi and the new sugar 
phosphate. We therefore conclude that in the intact 
cells the 31P resonances of all the vesicular contents 
are very broad (in agreement with [24]), although 
the broadening appears to be different for different 
resonances. It is possible that the broad resonances in 
fig.3(b) arise from vesicular ADP, whilst the resonances 
of ATP and pyrophosphate are yet broader. The spectra 
of both untreated and treated cells in fig.3 contain a 
broad component in the baseline, which may be 
attributed to phospholipids of cell membranes. 
4. Discussion 
The 31P resonances of molecules in the platelet 
cytoplasm are well resolved with linewidths compa- 
rable with those of the contents of other cells. Some 











Fig.4. 109 MHz 3’P NMR spectra of perchloric acid extracts 
of: (a) untreated platelets; (b) platelets treated with Zdeoxy- 
D-glucose and antimycin A. Peak assignments; (1) 2deoxy- 
Dglucosed-phosphate; (2) sugar and nucleotide monophos- 
phates (3) Pi; (4) unassigned; (5) ATP y-; (6) ADP p-; 
(7) pyrophosphate; (8) ADP CY-: (9) ATP, W; (10) unassigned; 
(11) ATP, p-. 
ATP resonances. The “F resonance of 2-fluoro-AMP 
or 2fluoroadenosine is sharp, and in separate work 
[25] we have observed sharp resonances from 2-fluoro- 
2-deoxy-D-glucose-6-phosphate in cells. However, 
the “F resonance of 2-fluoro-ATP is very broad, and 
the linewidth is field dependent. In red blood cells, 
we have found similar characteristics of the 2-fluoro- 
ATP “F resonance [25]. There are several possible 
reasons for the linebroadening associated with the 
cytoplasmic ATP, including varying magnetic suscep- 
tibility across the cells and effects of paramagnetic 
ions. However, the former cannot explain the large 
difference in linewidths for the different nuclei, or 
the different linewidths of fluorinated molecules in 
the cytoplasm. The effects of paramagnetic ions 
would be more pronounced on 31P resonances of ATP, 
to which they bind, than on the “F resonance of the 
nucleotide base. This is the opposite of the observed 
effects. The field dependence of the “F linewidths of 
2-fluoro-ATP therefore indicates that the broadening 
arises either from chemical exchange or from chemical 
shifts anisotropy. If chemical exchange effects are respon- 
sible, then considerable chemical shift perturbation must 
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arise presumably from relatively strong binding of the 
ATP to another species. An alternative mechanism for 
relaxation, however, is chemical shift anisotropy [26], 
which has been observed previously in 19F spectra of 
large molecules [27] and in 31P spectra of, e.g., phos- 
pholipids [28]. If this is the correct mechanism, the 
dipolar contribution to the 19F linewidth of 2-fluoro- 
ATP is < 80 Hz. The r9F chemical shift tensor of 
2-fluoro-ATP is not known although the tensors for 
some substituted benzenes have been determined [29]. 
These vary in an unpredictable manner, but a calcula- 
tion shows that for isotropic tumbling, the correlation 
time (rc) for the motion of the fluorine atom of 
2.fluoro-ATP would be about IO-’ s. This would not 
be inconsistent with the relatively well resolved 31P 
spectra, because the smaller magnetogyric ratio of the 
31P nucleus would, even if the shift tensor were the 
same as for the 19F nucleus, reduce the broadening 
of the 31P resonances by a factor > 5. Regardless of 
the mechanism of relaxation, however, the data indi- 
cate that ATP in the cytoplasm does not exist as a 
freely tumbling, unbound species. 
The linewidths of the 19F and 31P resonances of all 
the molecules in the platelet vesicles, unlike the cyto- 
plasm, are so broad as to be effectively unobservable. 
This observation contrasts markedly with NMR studies 
of chromaffin granules, both inside adrenomedullary 
cells and following biochemical isolation, where well- 
resolved ‘H, 13C and 3’P resonances are observed 
[3,30-321. The linebroadening, likely to be 
dominated by chemical shift anisotropy, indicates 
that the contents of the platelet vesicleshave very highly 
restricted motional freedom. A reasonable explana- 
tion is that the vesicular serotonin and nucleotides 
are bound in highly aggregated complexes with Ca’+. 
It is to be noted that the chromaffin granules do not 
contain high concentrations of metal ions, and that 
their contents undergo relatively unrestricted molecular 
tumbling. Full details of the structural nature of the 
platelet vesicles remain to be established, as does the 
significance of the present observation in an under- 
standing of their biological function. 
It is clear from this study that r9F NMR studies of 
cells employing fluorinated molecules constrained to 
specific cellular compartments complement studies of 
other nuclei, and that the degree of molecular motion 
prevailing for different molecules inside these compart- 
ments can be investigated. 
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